Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: Aripiprazole in the Treatment of Bipolar Depression [NA]

View source ↗

Summary

Update on a completed clinical trial evaluating aripiprazole for bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Bipolar Disorder | NA | Status: COMPLETED